Latest News

Avista Corporation reported third quarter and nine-month results, posting increases in both revenue and net income compared to the prior year, including US$403 million in quarterly sales and net income of US$29 million. This marks a period of stronger earnings performance, with basic earnings per share from continuing operations rising to US$0.36 for the quarter. We'll examine how Avista's improved quarterly profitability may shape its investment narrative and future growth outlook. We've...

Ur-Energy (TSX:URE) is forecast to grow revenue at an impressive 34% annually, far outpacing the Canadian market’s 5.1% yearly growth rate. Despite this top-line momentum, the company remains unprofitable, with annual losses deepening by 32.5% over the past five years and no improvement in net profit margins. Investors weighing these results will note that while strong revenue growth is a clear highlight, persistent losses continue to overshadow earnings quality. See our full analysis for...

Wondering if West Pharmaceutical Services is a bargain or a bubble? You are not alone, as investors of all stripes are eager to know what the current price really means. The stock has seen mild swings recently, ticking up 1.2% over the last week and 5.3% over the past month. However, it is still down 12.6% year-to-date and 11.0% over the past year, hinting at shifting optimism and risk perceptions. Recent headlines have highlighted ongoing industry innovation and regulatory changes, putting...

Axcelis Technologies (ACLS) posted a net profit margin of 15.9%, down from 20.6% a year ago, as recent earnings growth turned negative. Looking ahead, analysts forecast earnings to decline by 7.3% annually over the next three years, with revenue growth expected to slow to 1.1% per year compared to a much faster 10.5% rate for the broader US market. Despite slowing fundamentals, the stock trades at a favorable 18.4x price-to-earnings ratio, which is well below its semiconductor peers, and sits...

Wondering if Bavarian Nordic is a hidden gem or simply riding the latest biotech wave? Let's dig in and see if the stock is living up to its reputation. Bavarian Nordic shares have seen a solid 18.2% jump year-to-date and are up 13.6% over the past year, but there was a slight dip of 0.6% just last week. Recent headlines highlight the company's expanding role in vaccine development, with positive investor sentiment driven by new partnerships and regulatory milestones. These developments have...

Wondering if Siemens Healthineers is trading at a great price or if you are chasing the story too late? You are not alone. Let's dig into what the current market is saying. The stock has nudged up 0.8% over the past week and managed a steady 3.5% gain for the year, signaling renewed interest and possibly shifting risk perceptions. Recent news around advancements in medical imaging technology and key partnerships have been grabbing headlines, giving investors more to weigh as the company...

If you have ever wondered whether Alliance Resource Partners shares are genuinely good value or simply riding high, you are in the right place for a clear-eyed assessment. After a strong multi-year climb of more than 1000% over five years, the stock’s momentum has slowed, with a modest 1.2% gain this week but a dip of 7.5% year-to-date. Industry headlines have centered on energy market volatility and shifting attitudes toward coal stocks. Alliance Resource Partners has appeared regularly in...

Waters (WAT) reported net profit margins of 20.9%, slightly below last year’s 21.4%. Earnings have grown by 1% annually over the past five years, with EPS up 4.3% over the past year and outpacing the longer-term trend. Revenue is projected to accelerate at 12.3% per year, while earnings are expected to climb 29.4% annually. This means both are set to outpace the broader US market. See our full analysis for Waters. Next, we will see how these fresh results line up with market narratives,...

Novanta (NOVT) posted a 7.1% annual EPS growth rate over the past five years, but in the most recent year, earnings declined and net profit margins narrowed to 5.5% from 6.5% previously. The bottom line was further impacted by a one-time, $26 million loss, resulting in another layer of pressure on last year’s results. Looking forward, consensus is calling for profits to rebound sharply at 51.5% per year over the next three years, far outpacing the broader US market's 16% annual rate. However,...

Hillman Solutions (HLMN) reported net profit margins of 2.4%, up from last year’s 0.6%, reflecting a notable improvement in profitability. The company delivered a profit growth of 346.7% over the past year, significantly outpacing its five-year average of 57.2% per year. It has now maintained profitable results for several consecutive years. With forecasts pointing to annual earnings growth of 30.3%, investors are weighing the potential for continued momentum against persistent concerns about...

Martin Marietta Materials (MLM) posted a net profit margin of 17.2%, down from last year’s 30.5%, highlighting a notable decline in profitability. The results include a substantial one-off gain of $1.3 billion, impacting the latest figures. Earnings have grown at an average annual rate of 19.6% over the past five years. Looking ahead, analysts forecast earnings growth of 10.6% per year and revenue growth of 6.9% per year, both lagging the broader US market outlook. The current...

Thomson Reuters (TSX:TRI) is forecast to deliver annual earnings growth of 8.6% and revenue growth of 7.5% per year. Revenue growth is expected to outpace the Canadian market average of 5.1%. Recent profit margins have tightened to 23.8%, down from last year’s 31.2%, while earnings have declined by 18% per year over the past five years. Although profits are expected to pick up, the anticipated growth is modest and trails the high-growth benchmarks investors often look for during earnings...

NewPrinces (BIT:NWL) shares have delivered a strong year so far, climbing more than 62% since January. Even with recent dips over the month and past 3 months, long-term investors have seen considerable returns. See our latest analysis for NewPrinces. NewPrinces has clearly caught the market’s attention this year, with a 62.5% year-to-date share price return that highlights enduring momentum despite recent pullbacks. Long-term investors have been rewarded even more handsomely, as the stock’s...

Digi Power X Inc. recently announced the appointment of Ajay Gupta, a prominent wealth management executive and advisor, to its board of directors, effective October 21, 2025. Gupta’s influential roles at major financial organizations and personal connections with top industry leaders add recognized leadership and expertise to Digi Power X’s board. We'll examine how the addition of a widely respected financial leader shapes Digi Power X's investment narrative and future direction. Rare earth...

UFP Technologies (UFPT) reported net profit margins of 11.2%, down from 11.7% a year ago, with recent annual earnings growth of 23.8% underperforming its five-year average of 31.6%. Looking ahead, earnings are forecast to rise at 14.33% per year and revenue growth is expected at 5.6% annually, which trails the broader US market’s 10.5% projected pace. While the company's Price-to-Earnings Ratio of 25.6x sits below the US Medical Equipment industry average but above its peer group, shares are...

Wondering if Kennedy-Wilson Holdings is now a value play or if there is more trouble ahead? Let’s dive in and see whether curiosity is rewarded. The stock has tumbled in 2024, dropping 24.7% year-to-date and losing over 28% across the last twelve months as investor sentiment has shifted quickly. Recent headlines have centered on industry-wide volatility in real estate, with rising interest rates and macro uncertainty putting pressure on REITs and property holding firms like Kennedy-Wilson...

Wondering if Qiagen is a smart buy right now? You are not alone, as there has been a lot of chatter lately about whether the current share price offers real value to investors. The stock has dipped 7.9% in the past week and 5.6% over the last month, with a somewhat muted 3.6% decline year-to-date. However, it has managed to eke out a modest 1.0% gain over the past year. Qiagen has caught attention recently with its ongoing innovations in biotech solutions and a series of new product...

Wondering if NPK International is actually a bargain or just riding market hype? You’re not alone, and we’re about to dig into the numbers together. The stock has delivered an impressive 63.9% gain so far this year, with a substantial 80.9% return over the past 12 months. However, the last week saw a slight dip of 4.7%. Just last month, NPK International made headlines by announcing a strategic partnership aimed at expanding into new international markets. Many observers believe this move is...

Upbound Group (UPBD) just released its third-quarter results, revealing higher sales and revenue compared to last year, although profits decreased. Along with the earnings announcement, the company named Hal Khouri as its new Chief Financial Officer. See our latest analysis for Upbound Group. Despite higher sales and a new CFO appointment, Upbound Group’s recent momentum has been choppy, with a 1-year total shareholder return of -32.07% and a year-to-date share price return of -30.87%. While...

Wondering if Viridian Therapeutics is truly a bargain or simply treading water? Here is a closer look at what makes this stock potentially interesting for value-minded investors. The share price climbed 8.3% in the past month but is still down 7.1% over the last year. This may suggest shifting investor sentiment and possible untapped growth. Markets have responded dynamically to the company’s recent announcement of promising results from its pipeline treatments for rare diseases. These...

Gjensidige Forsikring (OB:GJF) just posted its latest earnings, revealing a dip in quarterly net income and earnings per share from last year's third quarter. However, strong nine-month results highlight notable year-on-year gains for the insurer. See our latest analysis for Gjensidige Forsikring. Gjensidige Forsikring’s latest earnings have added some nuance to the stock’s upward journey this year. Despite a softer third quarter, the 2025 nine-month results impressed investors and helped...

Kforce (KFRC) posted a net profit margin of 3%, down from 3.9% a year ago, with earnings sliding by an average of 8% per year over the past five years. Revenue is forecast to grow at just 1.5% annually, behind the broader US market’s 10.5% growth forecast, and earnings are expected to rise 10.9%, also trailing the market’s 16% target. However, the company trades at a price-to-earnings ratio of 13.7x, well below industry averages, and is noted for high quality earnings and an attractive...

Truecaller (OM:TRUE B) released its latest earnings report, drawing investor focus as sales for the third quarter and nine-month period grew year over year, while profits saw a decline. See our latest analysis for Truecaller. Despite steady sales growth, Truecaller’s share price return over the past year has been sharply negative, with a 1-year share price return of -46.42% and a total shareholder return of -40.80%. Recent quarterly results and declining profits appear to have weighed on...

MasterBrand, Inc. recently announced third quarter 2025 earnings, reporting US$698.9 million in sales and US$18.1 million in net income, both lower than the prior year; the company also shared updated full-year guidance, anticipating flat net sales and an organic decrease by mid single-digits for 2025. In response to newly enacted tariffs, MasterBrand outlined a comprehensive plan involving pricing adjustments, supplier negotiations, and manufacturing optimization to address potential margin...